AuraVax Therapeutics Inc
Houston, Texas, United States
Purpose
to develop novel transmission blocking compounds against respiratory viruses for low and middle income populations
Division
Global Health
Date
June 2025
Region Served
GLOBAL
Committed amount
$235,615
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
9
Grantee location
Houston, Texas, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.